323 related articles for article (PubMed ID: 37833981)
1. The Diagnosis and Management of Cutaneous Metastases from Melanoma.
Di Raimondo C; Lozzi F; Di Domenico PP; Campione E; Bianchi L
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833981
[TBL] [Abstract][Full Text] [Related]
2. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
3. Novel Targets in Melanoma: Intralesional and Combination Therapy to Manipulate the Immune Response.
Gingrich AA; Kirane AR
Surg Oncol Clin N Am; 2020 Jul; 29(3):467-483. PubMed ID: 32482321
[TBL] [Abstract][Full Text] [Related]
4. The cutaneous manifestations of metastatic malignant melanoma.
Reed KB; Cook-Norris RH; Brewer JD
Int J Dermatol; 2012 Mar; 51(3):243-9. PubMed ID: 22348556
[TBL] [Abstract][Full Text] [Related]
5. Metastatic melanoma - a review of current and future treatment options.
Maverakis E; Cornelius LA; Bowen GM; Phan T; Patel FB; Fitzmaurice S; He Y; Burrall B; Duong C; Kloxin AM; Sultani H; Wilken R; Martinez SR; Patel F
Acta Derm Venereol; 2015 May; 95(5):516-24. PubMed ID: 25520039
[TBL] [Abstract][Full Text] [Related]
6. [Melanoma, from diagnosis to treatment].
Baroudjian B; Pagès C; Lebbé C
Rev Infirm; 2016 Mar; (219):16-8. PubMed ID: 26944639
[TBL] [Abstract][Full Text] [Related]
7. Satellite in transit metastases in rapidly fatal conjunctival melanoma: implications for angiotropism and extravascular migratory metastasis (description of a murine model for conjunctival melanoma).
Barnhill RL; Lemaitre S; Lévy-Gabrielle C; Rodrigues M; Desjardins L; Dendale R; Vincent-Salomon A; Roman-Roman S; Lugassy C; Cassoux N
Pathology; 2016 Feb; 48(2):166-76. PubMed ID: 27020389
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases.
Zaremba A; Philip M; Hassel JC; Glutsch V; Fiocco Z; Loquai C; Rafei-Shamsabadi D; Gutzmer R; Utikal J; Haferkamp S; Reinhardt L; Kähler KC; Weishaupt C; Moreira A; Thoms KM; Wilhelm T; Pföhler C; Roesch A; Ugurel S; Zimmer L; Stadtler N; Sucker A; Kiecker F; Heinzerling L; Meier F; Meiss F; Schlaak M; Schilling B; Horn S; Schadendorf D; Livingstone E
Eur J Cancer; 2021 Jul; 152():139-154. PubMed ID: 34102453
[TBL] [Abstract][Full Text] [Related]
9. [Immunotherapy for malignant melanoma].
Zaremba A; Zimmer L; Griewank KG; Ugurel S; Roesch A; Schadendorf D; Livingstone E
Internist (Berl); 2020 Jul; 61(7):669-675. PubMed ID: 32462249
[TBL] [Abstract][Full Text] [Related]
10. SEOM clinical guideline for the management of cutaneous melanoma (2020).
Majem M; Manzano JL; Marquez-Rodas I; Mujika K; Muñoz-Couselo E; Pérez-Ruiz E; de la Cruz-Merino L; Espinosa E; Gonzalez-Cao M; Berrocal A
Clin Transl Oncol; 2021 May; 23(5):948-960. PubMed ID: 33651321
[TBL] [Abstract][Full Text] [Related]
11. Novel treatments for melanoma brain metastases.
Kenchappa RS; Tran N; Rao NG; Smalley KS; Gibney GT; Sondak VK; Forsyth PA
Cancer Control; 2013 Oct; 20(4):298-306. PubMed ID: 24077406
[TBL] [Abstract][Full Text] [Related]
12. Management of Locoregionally Advanced Melanoma.
Pointer DT; Zager JS
Surg Clin North Am; 2020 Feb; 100(1):109-125. PubMed ID: 31753106
[TBL] [Abstract][Full Text] [Related]
13. The Emerging Therapeutic Landscape of Advanced Melanoma.
Henriques V; Martins T; Link W; Ferreira BI
Curr Pharm Des; 2018; 24(5):549-558. PubMed ID: 29366407
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous Melanoma-A Review in Detection, Staging, and Management.
Hartman RI; Lin JY
Hematol Oncol Clin North Am; 2019 Feb; 33(1):25-38. PubMed ID: 30497675
[TBL] [Abstract][Full Text] [Related]
15. Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management.
Ireland A; Millward M; Pearce R; Lee M; Ziman M
Clin Exp Metastasis; 2011 Apr; 28(4):327-36. PubMed ID: 21311956
[TBL] [Abstract][Full Text] [Related]
16. Complete Resolution of Bilateral Choroidal Metastases of Cutaneous Melanoma With Combined Targeted Therapy.
Szalai E; Csutak A; Lengyel Z
Retina; 2021 Mar; 41(3):e30-e31. PubMed ID: 33323905
[No Abstract] [Full Text] [Related]
17. Intralesional treatment of metastatic melanoma: a review of therapeutic options.
Weide B; Neri D; Elia G
Cancer Immunol Immunother; 2017 May; 66(5):647-656. PubMed ID: 28078357
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?
Franceschini D; Franzese C; Navarria P; Ascolese AM; De Rose F; Del Vecchio M; Santoro A; Scorsetti M
Cancer Treat Rev; 2016 Nov; 50():1-8. PubMed ID: 27566962
[TBL] [Abstract][Full Text] [Related]
19. The immune system--a hidden treasure for biomarker discovery in cutaneous melanoma.
Neagu M
Adv Clin Chem; 2012; 58():89-140. PubMed ID: 22950344
[TBL] [Abstract][Full Text] [Related]
20. Locoregional cutaneous metastases of malignant melanoma and their management.
Wolf IH; Richtig E; Kopera D; Kerl H
Dermatol Surg; 2004 Feb; 30(2 Pt 2):244-7. PubMed ID: 14871216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
